PUBLICACIONES
Intensity normalization methods in brain FDG-PET quantification.
López-González FJ, Silva-Rodríguez J, Paredes-Pacheco J, Niñerola-Baizán A, Efthimiou N, Martín-Martín C, Moscoso A, Ruibal Á, Roé-Vellvé N, Aguiar P. Neuroimage. 2020 Nov 15;222:117229.
White matter hyperintensities are associated with subthreshold amyloid accumulation.
Moscoso A, Rey-Bretal D, Silva-Rodríguez J, Aldrey JM, Cortés J, Pías-Peleteiro J, Ruibal Á, Aguiar P; Alzheimer’s Disease Neuroimaging Initiative. Neuroimage. 2020 Sep;218:116944
Prediction of Alzheimer’s disease dementia with MRI beyond the short-term: Implications for the design of predictive models.
Moscoso A, Silva-Rodríguez J, Aldrey JM, Cortés J, Fernández-Ferreiro A, Gómez-Lado N, Ruibal Á, Aguiar P; Alzheimer's Disease Neuroimaging Initiative. Neuroimage Clin. 2019;23:101837.
Spill-in counts in the quantification of 18F-florbetapir on Aβ-negative subjects: the effect of including white matter in the reference region.
López-González FJ, Moscoso A, Efthimiou N, Fernández-Ferreiro A, Piñeiro-Fiel M, Archibald SJ, Aguiar P, Silva-Rodríguez J; Alzheimer’s Disease Neuroimaging Initiative. EJNMMI Phys. 2019 Dec 19;6(1):27.
PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36.
Aguiar P, Pardo J, Arias M, Quintáns B, Fernández-Prieto M, Martínez-Regueiro R, Pumar JM, Silva-Rodríguez J, Ruibal Á, Sobrido MJ, Cortés J. Mov Disord. 2017 Feb;32(2):264-273.
Effect of anatomical variability, reconstruction algorithms and scattered photons on the SPM output of brain PET studies.
Aguiar P, Pareto D, Gispert JD, Crespo C, Falcón C, Cot A, Lomeña F, Pavía J, Ros D. Neuroimage. 2008 Feb 1;39(3):1121-8.
Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?
Piñeiro-Fiel M, Moscoso A, Lado-Cacheiro L, Pombo-Pasín M, Rey-Bretal D, Gómez-Lado N, Mondelo-García C, Silva-Rodríguez J, Pubul V, Sánchez M, Ruibal Á, Aguiar P. Eur Radiol. 2020 Nov 27. doi: 10.1007/s00330-020-07507-z.
Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer.
Moscoso A, Ruibal Á, Domínguez-Prado I, Fernández-Ferreiro A, Herranz M, Albaina L, Argibay S, Silva-Rodríguez J, Pardo-Montero J, Aguiar P. Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):196-206.
Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies.
Silva-Rodríguez J, Aguiar P, Sánchez M, Mosquera J, Luna-Vega V, Cortés J, Garrido M, Pombar M, Ruibal A. Med Phys. 2014 May;41(5):052502.
Impact and correction of the bladder uptake on 18 F-FCH PET quantification: a simulation study using the XCAT2 phantom.
Silva-Rodríguez J, Tsoumpas C, Domínguez-Prado I, Pardo-Montero J, Ruibal Á, Aguiar P. Phys Med Biol. 2016 Jan 21;61(2):758-73.
[18F]-FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage.
Gómez-Lado N, López-Arias E, Iglesias-Rey R, Díaz-Platas L, Medín-Aguerre S, Fernández-Ferreiro A, Posado-Fernández A, García-Varela L, Rodríguez-Pérez M, Campos F, Del Pino P, Ruibal Á, Pardo-Montero J, Castillo J, Aguiar P, Sobrino T. Mol Pharm. 2020 Dec 7;17(12):4667-4675.
PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats.
Luaces-Rodríguez A, Del Amo EM, Mondelo-García C, Gómez-Lado N, Gonzalez F, Ruibal Á, González-Barcia M, Zarra-Ferro I, Otero-Espinar FJ, Fernández-Ferreiro A, Aguiar P. Eur J Pharm Biopharm. 2020
